Identifying Important Clinical Symptoms in Children With Severe Neurological Impairment Using Parent-Reported Outcomes of Symptoms.
James A Feinstein, Chris Feudtner, Robert J Valuck...
https://pubmed.ncbi.nlm.nih.gov/33044500/Actively Recruiting
Led by University of Colorado, Denver · Updated on 2026-04-28
371
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are evaluating whether Pediatric Medication Therapy Management pMTM can improve how medication-related problems are identified and managed in children with complex medical conditions who take multiple medications. This study compares the usual care medication management with the pMTM intervention, focusing on children aged 2 to 18 years who have complex chronic conditions and are taking at least five medications. Participants are randomly assigned to one of two groups the usual care group, which receives standard medication management during routine clinical visits, and the intervention group, which receives the pMTM approach before their routine visit. The pMTM intervention involves a comprehensive review of all medications, optimization of the medication regimen, and creation of a personalized medication action plan. During the study, researchers will track how many medication-related problems occur over 90 days, changes in parent-reported symptoms from the start to 90 days, and the number of acute healthcare visits within 90 days. Children and their parents will be involved in the study through regular clinical visits and assessments, allowing researchers to measure the effectiveness of the intervention in managing medications safely and effectively.
CONDITIONS
Pediatric Medication Therapy Management Trial
J
James A Feinstein, MD, MPH
A
Anowara Begum, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Colorado, Denver
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | pMTM (Medication Therapy Management) | Usual Care |
|---|---|---|
| What it is | A structured program that reviews all medicines a child takes, optimizes the regimen, and creates a medication action plan involving both healthcare providers and caregivers. | Standard pediatric care for children with complex chronic conditions, without dedicated medication management intervention beyond routine practice. |
| Role in trial | Investigational intervention to reduce medication-related problems and optimize medication use. | Comparator arm to measure outcomes against the pMTM intervention. |
| Primary use | Aims to identify and resolve medication-related problems and improve medication outcomes for children with medical complexity. | Provides usual clinical management of children with complex conditions and polypharmacy. |
| How it is given or performed | A clinical pharmacist completes a comprehensive review of all medications, discusses recommendations with the care team, and creates a tailored medication action plan for the family. | Medication management occurs as part of regular visits and ongoing care. No structured medication therapy management or formalized medication review as a separate process. |
| Evidence status | Currently under investigation; effects on medication-related problems, symptoms, and acute care visits are being studied in this trial. Early reports suggest that structured medication therapy management may help address polypharmacy and reduce errors in medically complex children, but large randomized trial outcomes are not yet known. | Usual care is established practice, but medication-related problems and errors remain common in children with medical complexity and polypharmacy. |
| Important limitations | As an investigational service, pMTM’s true impact on long-term clinical outcomes and practical integration into busy pediatric practices remains to be demonstrated. | In usual care, medication-related problems and regimen complexity frequently go unaddressed, raising the risk of medication errors or suboptimal symptom control for children with chronic and complex health needs. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 90 days
Participants receive either usual care medication management during a routine clinical visit or the Pediatric Medication Therapy Management (pMTM) intervention before a routine clinical visit.
1 to 2 visits depending on group assignment
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
James A Feinstein, Chris Feudtner, Robert J Valuck...
https://pubmed.ncbi.nlm.nih.gov/33044500/Clyde Marquez, Riley Thompson, James A Feinstein...
https://pubmed.ncbi.nlm.nih.gov/35527209/James A Feinstein, Hannah Friedman, Lucas E Orth...
https://pubmed.ncbi.nlm.nih.gov/34436607/Lucas E Orth, Chris Feudtner, Allison Kempe...
https://pubmed.ncbi.nlm.nih.gov/37120509/James A Feinstein, Chris Feudtner, Allison B Blackmer...
https://pubmed.ncbi.nlm.nih.gov/33306117/James A Feinstein, Matt Hall, James W Antoon...
https://pubmed.ncbi.nlm.nih.gov/30914443/University of Colorado, Denver
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborating Sponsor